Immunogenicity of Live Attenuated SA14–14–2 Japanese Encephalitis Vaccine—A Comparison of 1–and 3‐Month Immunization Schedules

Authors:

Abstract
Live attenuated SA14-14-2 Japanese encephalitis (JE) vaccine has been safe and effective in < 100 million immunized children, but its current admi